NASDAQ
Hansa Biopharma AB (publ) (HNSBF) has a total debt of $933.82M as of Wednesday, December 31, 2025. Total debt represents the sum of a company's short-term and long-term borrowings, indicating its overall leverage and financial obligations.
No price data available for this timeframe.